Fintech PR
Start-ups from across the globe look to woo investors with transformational tech shifts at world’s largest start-up event in Dubai
Expand North Star 2023 accelerates global VC investment revival as deep tech game-changers choose Dubai as launch-pad for global growth
Record number of Indian start-ups to converge at four-day event’s new iconic Dubai Harbour venue
DUBAI, UAE, Oct. 12, 2023 /PRNewswire/ — India’s burgeoning entrepreneurial spirit and proliferation of next-gen deep tech talent will take centre-stage next week in Dubai, as the world’s largest start-up event prepares to host the biggest showcase of Indian start-ups ever seen outside the south-central Asian nation.
Hosted by Dubai Chamber of Digital Economy, one of the three chambers under the umbrella of Dubai Chambers, Expand North Star 2023 together will feature more than 1,800 exhibiting start-ups from 100-plus countries at its new Dubai Harbour venue from 15-18 October. This includes 200 breakthrough Indian companies choosing the emirate as their launchpad to scale up globally.
From international award-winning Google accelerated gaming innovators, to producers of de-carbonised protein for the US$500 billion animal feed industry, game-changers from the world’s third-largest start-up ecosystem are gathering in Dubai to woo investors and secure customers for global expansion.
Sustainable Agri-tech the formidable foundation of future commerce
Among the pioneering start-ups at Expand North Star’s new India Central feature is Noval Sustainability, which is launching DE-Carbon, an animal feed protein recycled from waste that, according to Founder Siva Sankar, is formulated to substantially reduce the environmental footprint of the carbon-heavy feed and meat industries.
“We will showcase the tech behind recovering protein from waste,” said Sankar, who will demonstrate at Expand North Star how Noval Sustainability’s manufacturing process decarbonises one of the world’s largest and most-polluting industries.
“The world wastes more than 30 percent of the food that is produced, and the same ratio holds for the amount of proteins wasted from meat consumption. We are bridging the gap with a solution, and there’s a humongous untapped economic value in this waste. With an inclusion of just one percent of alternative proteins in animal feed, we’re looking at a US$500 billion industry.”
Scaling-up through deep tech immersive gaming
Elsewhere, investors in the US$300 billion gaming industry will see a fresh injection of deep tech gaming platforms, spearheaded by Tuttifrutti Interactive’s Sophia’s Adventures fantasy themed game that uses cinematic quality Unreal 5 Nanite technology.
Ajish Habib, CEO of Tuttifrutti Interactive, a Google-accelerated, Epic Games Mega Grant recipient, and winner of 15 international awards, said Sophia’s Adventures alpha version will redefine the female gaming market, propelling the company, and potential seed angel investors, to exponential growth.
“With its official launch for Sony PlayStation and VR2 market, Tuttifrutti will grow a minimum four times by 2025, and with an upcoming half a dozen IP games, we’ll scale-up over 165 times by 2028, targeting revenues of US$80 million,” said Habib.
“Immersive game tech coupled with AI and deep tech will revolutionise the gaming market, and we’re leveraging AI in all aspects in our product development, from designing game emotions, and fine-tuning design, to marketing, and customer acquisition.”
Unveiling growth roadmaps
Manifested through its power-packed conference programme, Expand North Star will present key Indian unicorn founders will unveil the critical global growth path to unstoppable success.
Headliners include Bhavish Aggarwal, CEO & Co-Founder of Ola Cabs & Ola Electric, India’s largest ridesharing company with over 1.5 million drivers; and Abiraj Singh Bhal, CEO & Founder of Urban Company, a Series F $2.8 billion company offering the largest home services platform in India and UAE.
Expand North Star’s 10X Stage will also feature Rajan Anandan, Managing Director of Peak XV and Surge, a rapid scale-up programme for start-ups in India and Southeast Asia. Anandan is focusing on developing Surge into the world’s top scale-up programme for start-ups by acting as an investment advisor and mentor to the programme’s founders. He will share his visions for India’s booming start-up ecosystem for 2023 and beyond.
Forging deep cross-border economic ties to accelerate growth
Ballooning to nearly double that of the previous year, Indian participation at Expand North Star 2023 comes as the UAE and India continue to amplify bi-lateral trade and investment opportunities.
Under the Comprehensive Economic Partnership Agreement, the UAE and India plan to double the value of non-oil trade from 2023 to 2030, reaching US$100 billion. According to Dubai Chambers, 30 percent of the emirate’s start-ups are Indian-owned, while 83,000 Indian companies are registered in Dubai. Indian firms and non-resident Indian owned entities have also created more than one million UAE jobs.
Expand North Star 2023 will intensify these achievements, convening more than 1,000 tech investors and Venture Capitalists from 70 countries with US$1 trillion of capital to inspire, and scale-up the world’s most sought-after start-ups.
Expand North Star is the powerhouse start-up event inspired by GITEX GLOBAL, the world’s largest tech show, which takes place from 16-20 October at the Dubai World Trade Centre (DWTC). The blockbuster duo, organised by DWTC, are spearheading the world’s biggest tech takeover in Dubai, spanning 2.7 million sq. ft. of exhibition space – a 40 percent increase over the previous year.
More information is available at www.expandnorthstar.com
Information for journalists:
Register as press here.
Press information and photographic material:
[Media Center]
On social media:
Facebook
Twitter
Instagram
LinkedIn
Youtube
Hashtag:
#ExpandNorthStar
About Dubai World Trade Centre (DWTC):
A global business facilitator since 1979, Dubai World Trade Centre (DWTC) is home to region’s leading purpose-built convention and exhibition centre. DWTC provides a platform for connecting people, products, innovation and ideas from around the world through a dynamic calendar of international trade exhibitions and its own roster of sector leading mega events. As a designated free zone, complemented by award-winning commercial real estate, DWTC plays an integral role in Dubai and the region’s growth story with an estimated total economic output of AED 200 Billion, attracting over 30 Million business visitors to Dubai over the past four decades.
Photo: https://mma.prnewswire.com/media/2245471/Expand_North_Star_Event_Dubai.jpg
View original content:https://www.prnewswire.co.uk/news-releases/start-ups-from-across-the-globe-look-to-woo-investors-with-transformational-tech-shifts-at-worlds-largest-start-up-event-in-dubai-301954834.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News7 days ago
Trina Storage Recognized as Tier 1 Energy Storage Manufacturer by BNEF for Second Consecutive Quarter
-
Latest News7 days ago
EQT to acquire WSO2, a leading global provider of digital transformation technologies
-
Latest News7 days agoGenome and Chilli Partners join forces to revolutionize iGaming affiliate payouts
-
Latest News7 days ago
Bank of Spain grants Amadeus’ Outpayce EMI licence
-
Latest News7 days ago
Newmark Reports First Quarter 2024 Financial Results
-
Latest News7 days ago
Lunar Poised for Nationwide Rollout in Sweden After Securing €24.1 Million in Funding
-
Latest News6 days ago
REALTY ONE GROUP CELEBRATES 19TH ANNIVERSARY WITH GLOBAL ‘ONE DAY’ OF VOLUNTEERING & GIVING BACK
-
Latest News6 days ago
BIZCLIK MEDIA LAUNCHES MAY EDITION OF FINTECH MAGAZINE
